| Metric | შპს ფარმასი + | სს თიბისი ბანკი |
|---|---|---|
| Growth | ||
| Revenue | ₾3.1m₾3.5m | ₾2.36bn₾2.11bn |
| Revenue growth | -10.9% | 11.8% |
| Profitability | ||
| EBITDA | ₾116k₾378k | — |
| EBITDA margin | 3.7%10.7% | — |
| Net profit | ₾115k₾335k | ₾1.24bn₾1.12bn |
| Net margin | 3.7%9.5% | 52.8%53.0% |
| Balance sheet | ||
| Total assets | ₾1.3m₾1.4m | ₾37.66bn₾31.77bn |
| Total equity | ₾825k₾1.1m | ₾5.45bn₾4.75bn |
| ROE | 13.9%30.2% | 22.8%23.6% |